Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03725761
Title IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

prostate adenocarcinoma

Therapies

Sacituzumab govitecan-hziy

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.